Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
Objectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/2013/642836 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399126076162048 |
|---|---|
| author | Conrad V. Bishop Nikhil Vasdev Gregory Boustead James M. Adshead |
| author_facet | Conrad V. Bishop Nikhil Vasdev Gregory Boustead James M. Adshead |
| author_sort | Conrad V. Bishop |
| collection | DOAJ |
| description | Objectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month period. Demographic, operative, and outcome data was collected prospectively. Median patient age was 75 years (range 62–78 years). Median followup was 9 months (range 7–14 months). Results. RARC with RICIC was performed successfully in all eight patients. The median total operating time was 360 minutes (range 310–440 minutes) with a median blood loss of 225 mL (range 50–1000 mL). The median length of stay was nine days (range 6–34 days). Four patients (50%) were discharged within seven days. Four patients (50%) experienced one or more complications. This included two Clavien I complications, two Clavien II complications, and two Clavien III complications. Two patients (25%) required transfusion of two units each. To date, there have been no complications associated with the ileal conduit. Conclusion. Whilst being technically challenging, this procedure is safe, feasible, and reproducible. Patients who avoid complication show potential for rapid recovery and early discharge. |
| format | Article |
| id | doaj-art-a45fb55aeb9e41fd96fbbac0da4bc3c9 |
| institution | Kabale University |
| issn | 1687-6369 1687-6377 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Urology |
| spelling | doaj-art-a45fb55aeb9e41fd96fbbac0da4bc3c92025-08-20T03:38:24ZengWileyAdvances in Urology1687-63691687-63772013-01-01201310.1155/2013/642836642836Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK CentreConrad V. Bishop0Nikhil Vasdev1Gregory Boustead2James M. Adshead3Hertfordshire and South Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage SG14AB, UKHertfordshire and South Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage SG14AB, UKHertfordshire and South Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage SG14AB, UKHertfordshire and South Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage SG14AB, UKObjectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month period. Demographic, operative, and outcome data was collected prospectively. Median patient age was 75 years (range 62–78 years). Median followup was 9 months (range 7–14 months). Results. RARC with RICIC was performed successfully in all eight patients. The median total operating time was 360 minutes (range 310–440 minutes) with a median blood loss of 225 mL (range 50–1000 mL). The median length of stay was nine days (range 6–34 days). Four patients (50%) were discharged within seven days. Four patients (50%) experienced one or more complications. This included two Clavien I complications, two Clavien II complications, and two Clavien III complications. Two patients (25%) required transfusion of two units each. To date, there have been no complications associated with the ileal conduit. Conclusion. Whilst being technically challenging, this procedure is safe, feasible, and reproducible. Patients who avoid complication show potential for rapid recovery and early discharge.http://dx.doi.org/10.1155/2013/642836 |
| spellingShingle | Conrad V. Bishop Nikhil Vasdev Gregory Boustead James M. Adshead Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre Advances in Urology |
| title | Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre |
| title_full | Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre |
| title_fullStr | Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre |
| title_full_unstemmed | Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre |
| title_short | Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre |
| title_sort | robotic intracorporeal ileal conduit formation initial experience from a single uk centre |
| url | http://dx.doi.org/10.1155/2013/642836 |
| work_keys_str_mv | AT conradvbishop roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre AT nikhilvasdev roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre AT gregoryboustead roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre AT jamesmadshead roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre |